SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

CAC 40 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

DNA OYJ

DNA Oyj DNA Oyj

DNA Oyj



Company : DNA Oyj Compartment : Other
ISIN : FI4000062385 Wire : Thomson Reuters ONE
Document type : Annual General Meeting / Reports    
Publication date : 10/31/2019 10:15:00 AM    

Decisions of DNA Plc's Extraordinary General Meeting and organisation of Board of Directors

Decisions of DNA Plc's Extraordinary General Meeting and organisation of Board of Directors

DNA PLC STOCK EXCHANGE RELEASE 31 OCTOBER 2019, 11:15 pm (EEST)

DNA Plc's Extraordinary General Meeting was held in Helsinki on 31 October 2019.

The Extraordinary General Meeting approved the proposals of the shareholders' Nomination Committee for the number of Board members, members of the Board and their remuneration. The number of board members remains seven, and the following current Board members were re-elected; Anni Ronkainen, Kirsi Sormunen and Tero Ojanperä. Jørgen C. Arentz Rostrup, Nils Katla, Fredric Scott Brown and Ulrika Steg were elected as new Board members.

Nomination committee proposed that the remuneration of the Board members remains unchanged. The Chairman of the Board will be paid annual remuneration of EUR 144,000 and the members EUR 48,000 each. The meeting fee paid for Board meetings is EUR 1,050 per meeting and meeting fee per meeting of the Board's permanent committees is EUR 1,050 for the committee chairs and EUR 525 for each committee member.

Those Board members who are non-independent of DNA Plc’s major shareholders forgo their entitlement for the reward.

At the constitutive meeting of the Board of Directors held subsequent to the Extraordinary General Meeting, Jørgen C. Arentz Rostrup was elected Chair and members of the Audit Committee and the Personnel Committee were elected from among the Board members.
Kirsi Sormunen was elected as the Chair of the Audit committee and Tero Ojanperä and Nils Katla were elected as members of the Audit Committee.
Jørgen C. Arentz Rostrup was selected as the Chair of the Personnel Committee and Anni Ronkainen and Ulrika Steg were elected as members of the Personnel Committee.
Anni Ronkainen, Kirsi Sormunen and Tero Ojanperä are independent of the company and of the major shareholder. Jørgen C. Arentz Rostrup, Nils Katla, Fredric Scott Brown and Ulrika Steg are independent of the company but non-independent of the major shareholder.

Minutes of the Extraordinary General Meeting will be available on DNA's Investor website by 14 November 2019.

Further information:
Marja Mäkinen, Head of IR, DNA Plc, +358 44 044 1262, marja.makinen@dna.fi
DNA Corporate Communications, +358 44 044 8000, communications@dna.fi

DNA is one of the leading telecommunications companies in Finland. We want to make our customers' daily lives less complicated. We offer connections, services and devices for homes and workplaces, contributing to the digitalisation of society. DNA’s mobile communication network customers have the highest mobile data usage per subscription in the world. We are also Finland's largest cable TV operator and the leading pay-TV provider. DNA has more than 4 million subscriptions in its fixed and mobile communications networks. The company was ranked the best employer in Finland in the large companies category of the 2019 Great Place to Work survey. In 2018, our net sales were EUR 912 million and we employ about 1,600 people around Finland. DNA shares are listed on Nasdaq Helsinki Ltd. More information: www.dna.fi, Twitter @DNA_fi and Facebook.

]]>

BACK TO THE LIST